A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study (Q45377896)
Jump to navigation
Jump to search
scientific article published on 21 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study |
scientific article published on 21 February 2013 |
Statements
1 reference
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Fabrizio Querci
1 reference
Ivano G Franzetti
1 reference
Mario N Piccinni
1 reference
Anna Carbone
1 reference
21 February 2013
1 reference
1 reference
Identifiers
1 reference